Financials Biotrend Cevre ve Enerji Yatirimlari

Equities

BIOEN

TREBION00012

Electric Utilities

Market Closed - Borsa Istanbul 11:09:11 2024-06-05 am EDT 5-day change 1st Jan Change
19.19 TRY -1.18% Intraday chart for Biotrend Cevre ve Enerji Yatirimlari +9.66% +11.57%

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025
Capitalization 1 2,750 9,475 8,600 9,595 -
Enterprise Value (EV) 1 2,750 9,475 8,600 9,595 9,595
P/E ratio 262 x 30.5 x - - -
Yield - - - 3.91% 6.88%
Capitalization / Revenue - 7.7 x 3.85 x 2.6 x 1.92 x
EV / Revenue - 7.7 x 3.85 x 2.6 x 1.92 x
EV / EBITDA - 18.3 x 12.3 x 8.68 x 5.63 x
EV / FCF - - - - -
FCF Yield - - - - -
Price to Book - - - - -
Nbr of stocks (in thousands) 500,000 500,000 500,000 500,000 -
Reference price 2 5.500 18.95 17.20 19.19 19.19
Announcement Date 2/9/22 3/13/23 5/18/24 - -
1TRY in Million2TRY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022 2023 2024 2025
Net sales 1 - 1,231 2,233 3,684 4,990
EBITDA 1 - 518.3 700.3 1,105 1,704
EBIT - - - - -
Operating Margin - - - - -
Earnings before Tax (EBT) - - - - -
Net income 1 3.786 310.7 948.1 754 1,316
Net margin - 25.25% 42.46% 20.47% 26.37%
EPS 0.0210 0.6210 - - -
Free Cash Flow - - - - -
FCF margin - - - - -
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share 2 - - - 0.7500 1.320
Announcement Date 2/9/22 3/13/23 5/18/24 - -
1TRY in Million2TRY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2023 Q2 2023 Q3
Net sales 1 391.1 541.8
EBITDA 1 - 137.7
EBIT - -
Operating Margin - -
Earnings before Tax (EBT) - -
Net income 1 114.8 173
Net margin 29.36% 31.93%
EPS - -
Dividend per Share - -
Announcement Date 8/21/23 11/8/23
1TRY in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022 2023 2024 2025
Net Debt - - - - -
Net Cash position - - - - -
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow - - - - -
ROE (net income / shareholders' equity) - - - - -
ROA (Net income/ Total Assets) - - - - -
Assets 1 - - - - -
Book Value Per Share - - - - -
Cash Flow per Share - - - - -
Capex - - - - -
Capex / Sales - - - - -
Announcement Date 2/9/22 3/13/23 5/18/24 - -
1TRY in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
19.42 TRY
Average target price
28.9 TRY
Spread / Average Target
+48.82%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. BIOEN Stock
  4. Financials Biotrend Cevre ve Enerji Yatirimlari